Post-marketing clinical study of EPZICOM tablet (lamivudine / abacavir sulfate) - pharmacokinetic study in HIV-infected patients.
Phase of Trial: Phase IV
Latest Information Update: 27 May 2016
At a glance
- Drugs Lamivudine/abacavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 15 Oct 2008 Actual start date changed from May 2006 to July 2006 as reported by Clinicaltrials.gov.
- 21 Oct 2006 New trial record.